comparemela.com
Home
Live Updates
Annovis (ANVS): Late-Stage Parkinsons Disease Trial Advancement Makes It Worth A Look : comparemela.com
Annovis (ANVS): Late-Stage Parkinson's Disease Trial Advancement Makes It Worth A Look
Annovis is targeting large market indications and the two of them are Alzheimer's and Parkinson's. See why I believe that ANVS is a great speculative biotech play.
Related Keywords
Annovis Bio ,
Movement Disorder Society ,
National Institutes Of Health ,
Movement Disorder Society Sponsored Revision ,
Unified Parkinson ,
Disease Rating Scale ,
Participant Global Impression ,
Final Conclusion ,
National Institutes ,
comparemela.com © 2020. All Rights Reserved.